Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Autism risk in siblings of autistic children is higher: Study

A new study reveals that parents with an autistic child have a 19% increased chance of getting another one with a similar disorder. Experts said the study, published Monday in the journal Pediatrics, is the most comprehensive of its kind and should be used to counsel families.

17 Aug 2011

Addiction – a brain disorder say experts

According to the American Society of Addiction Medicine, addiction is a chronic brain disorder like any other chronic brain disease such as obsessive-compulsive disorder and body dysmorphic disorder. Neurological abnormalities like disruptions in neurotransmission and the reward system drive addiction, the group said in a statement.

17 Aug 2011

Researchers document how immune system can counteract advancement of Alzheimer's

For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.

17 Aug 2011

Study: Eye contact seems to act as an invitation for mimicry

Imitation may be the sincerest form of flattery but how do our brains decide when and who we should copy? Researchers from The University of Nottingham have found that the key may lie in an unspoken invitation communicated through eye contact.

17 Aug 2011

Semaphorin-PlexinD1 signaling pathway shows promise as therapeutic target for cancer treatment

In a new study published in the August 16th issue of Developmental Cell, researchers at NYU Langone Medical Center identified a molecular mechanism that guarantees that new blood vessels form in the right place and with the proper abundance.

17 Aug 2011

U-M's epilepsy surgery could successfully treat patients with seizures

John Ligerakis was told he had to learn to live with seizures that had made it challenging for him to work or drive a car. A young professional just starting his career, Ligerakis was devastated about what his future might bring.

17 Aug 2011

Volunteen Program at St. Jude Children's Research Hospital

Each summer, a select group of teenagers spend five weeks of their summer vacation to help children with cancer and other catastrophic diseases through the Volunteen Program at St. Jude Children's Research Hospital. The annual program allows teens to explore career paths and develop leadership and team-building skills while helping patients.

17 Aug 2011

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

17 Aug 2011

NIH study in mice shows potential new target for treatment of ADHD

A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.

17 Aug 2011

Study: Vitamin D directly terminates production of MS-causing protein

While for years scientists have noted an association between levels of vitamin D in a person's body and the person's ability to resist or minimize the effects of multiple sclerosis (MS), the mechanism involved has not been established.

17 Aug 2011

PTSD impairs ability to recognize emotions from facial expressions

Facial expressions convey strong cues for someone's emotional state and the ability to interpret these cues is crucial in social interaction. This ability is known to be compromised in many psychiatric and neurological disorders, such as social anxiety or Korsakoff's syndrome.

17 Aug 2011

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).

17 Aug 2011

Moderate social drinking reduces risk of dementia and cognitive impairment

Moderate social drinking significantly reduces the risk of dementia and cognitive impairment, according to an analysis of 143 studies by Loyola University Chicago Stritch School of Medicine researchers.

17 Aug 2011

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

Abbott announced today that the U.S. Food and Drug Administration has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).

17 Aug 2011

Fluctuations in brain signals explained: Spontaneous electrical background rhythms in the brain influence fMRI

Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using

16 Aug 2011

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

LYSOGENE announces the authorization by AFSSAPS (the French Agency for the Safety of Health Products) and by the Ethical Review Board of SAF-301, its leading intra-cerebral gene therapy phase I/II clinical trial aiming at treating Sanfilippo Type A Syndrome.

16 Aug 2011

Study investigates autism spectrum disorder, sibling recurrence

The risk that an infant with an older sibling with autism also will develop the disorder, previously estimated at between 3 and 10 percent, is substantially higher at approximately 19 percent, a large, international, multi-site study led by researchers at the UC Davis MIND Institute has found.

16 Aug 2011

Modified Cdk5 enzyme triggers damage to nerve cell connections in human Alzheimer's brains

Alzheimer's disease is characterized by abnormal proteins that stick together in little globs, disrupting cognitive function. These sticky proteins are mostly made up of beta-amyloid peptide. A better understanding of these proteins, how they form, and how they affect brain function will no doubt improve the diagnosis and treatment of Alzheimer's disease.

16 Aug 2011

Biochemist develops polymer material to convert precursor cells into functional neurones

Nervous system diseases are especially difficult to treat, as it is not easy to replace the parts of the neural puzzle which are damaged. The key is in developing functional neurons from in vitro-treated, cells but for this it is essential that the support on which these cells are based simulate the characteristics of the nervous system.

16 Aug 2011

Green tea shows promise against two types of tumors, HHS

A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.

16 Aug 2011

Brain News and Research

Further Reading

Autism risk in siblings of autistic children is higher: Study

Addiction – a brain disorder say experts

Researchers document how immune system can counteract advancement of Alzheimer's

Study: Eye contact seems to act as an invitation for mimicry

Semaphorin-PlexinD1 signaling pathway shows promise as therapeutic target for cancer treatment

U-M's epilepsy surgery could successfully treat patients with seizures

Volunteen Program at St. Jude Children's Research Hospital

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

NIH study in mice shows potential new target for treatment of ADHD

Study: Vitamin D directly terminates production of MS-causing protein

PTSD impairs ability to recognize emotions from facial expressions

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Moderate social drinking reduces risk of dementia and cognitive impairment

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

Fluctuations in brain signals explained: Spontaneous electrical background rhythms in the brain influence fMRI

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

Study investigates autism spectrum disorder, sibling recurrence

Modified Cdk5 enzyme triggers damage to nerve cell connections in human Alzheimer's brains

Biochemist develops polymer material to convert precursor cells into functional neurones

Green tea shows promise against two types of tumors, HHS

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News